Download Files:
Products Details
Product Description
– INSCoV-614(1B) is a potent inhibitor of Mpro (3CLpro). Proteases (PL pro and 3CL pro) are involved with transcription and replication of the virus. INSCoV-614(1B) has the potential for the research of SARS-CoV-2 infection (extracted from patent WO2021219089A1)[1].
Web ID
– HY-144062
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C23H21ClF3N5O3
References
– [1]Aleksandrs Zavoronkovs, et al. Sars-cov-2 inhibitors having covalent modifications for treating coronavirus infections. Patent WO2021219089A1.
CAS Number
– 2735704-33-1
Molecular Weight
– 507.89
SMILES
– Cl[C@H](F)C(N(C1=CC=C(C2=CC=NO2)C=C1)[C@@H](C3=CN=CN=C3)C(NC4CCC(F)(CC4)F)=O)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– SARS-CoV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
